Back
Cornerstone Total Return Fund Vs. Nektar Therapeutics Industry Stock Comparison
Buy
67
CRF
Cornerstone Total Return Fund
Last Price:
$7.79
Seasonality Move:
2.13%
Sell
42
NKTR
Nektar Therapeutics
Last Price:
$44.64
Seasonality Move:
11.58%
Buy
67
Cornerstone Total Return Fund (CRF)
is a Buy
Is Cornerstone Total Return Fund a Buy, Sell or Hold?
-
The current Cornerstone Total Return Fund [CRF] share price is $7.80. The Score for CRF is 67, which is 34% above its historic median score of 50, and infers lower risk than normal.
-
CRF is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
42
Nektar Therapeutics (NKTR)
is a Sell
Is Nektar Therapeutics a Buy, Sell or Hold?
-
The current Nektar Therapeutics [NKTR] share price is $49.16. The Score for NKTR is 42, which is 16% below its historic median score of 50, and infers higher risk than normal.
-
NKTR is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
CRF Stock Price Chart
What is Cornerstone Total Return Fund's stock price today?
-
The Cornerstone Total Return Fund share price today is $7.80Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and CRF is experiencing selling pressure, which indicates risk of future bearish movement.
NKTR Stock Price Chart
What is Nektar Therapeutics's stock price today?
-
The Nektar Therapeutics share price today is $49.16Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and NKTR is experiencing slight buying pressure.
CRF Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.01 | Sell |
| Relative Strength Index (14 RSI): | 39.19 | Sell |
| Chaikin Money Flow: | -718654 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (7.8 - 8.02) | Sell |
| Bollinger Bands (100): | (7.82 - 8.04) | Sell |
NKTR Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -1.43 | Sell |
| Relative Strength Index (14 RSI): | 38.92 | Sell |
| Chaikin Money Flow: | 341847 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | ( - ) | Buy |
| Bollinger Bands (100): | ( - ) | Buy |
CRF Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 7.95 | Sell |
| 20-day SMA: | 7.9 | Sell |
| 50-day SMA: | 7.97 | Sell |
| 200-day SMA: | 7.63 | Buy |
| 8-day EMA: | 7.92 | Sell |
| 20-day EMA: | 7.93 | Sell |
| 50-day EMA: | 7.94 | Sell |
| 200-day EMA: | 7.87 | Sell |
NKTR Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 54.87 | Sell |
| 20-day SMA: | 57.43 | Sell |
| 50-day SMA: | 58.05 | Sell |
| 200-day SMA: | 31.04 | Buy |
| 8-day EMA: | 54.11 | Sell |
| 20-day EMA: | 56.28 | Sell |
| 50-day EMA: | 55.42 | Sell |
| 200-day EMA: | 38.13 | Buy |
Cornerstone Total Return Fund Earnings Growth & CRF Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
Nektar Therapeutics Earnings Growth & NKTR Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.41 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.41 per share, and a decrease next year of $0.27 per share.
Cornerstone Total Return Fund Technical Analysis
| Dec 3 | Dec 4 | Dec 5 | Dec 8 | Dec 9 | Dec 10 | Dec 11 | Dec 12 | Dec 15 | Dec 16 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 03 | 04 | 05 | 08 | 09 | 10 | 11 | 12 | 15 | 16 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Nektar Therapeutics Technical Analysis
| Dec 3 | Dec 4 | Dec 5 | Dec 8 | Dec 9 | Dec 10 | Dec 11 | Dec 12 | Dec 15 | Dec 16 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 03 | 04 | 05 | 08 | 09 | 10 | 11 | 12 | 15 | 16 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||